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After over 40 years of progress, gene therapy provides great 
opportunities for treating diseases from various genetic dis-
orders, infections and cancers. The success of gene therapy 
largely depends on the availability of suitable gene vectors. 
As an attractive alternative to virus-based gene therapy, 
non-viral gene delivery system has been developed and in-
vestigated due to their merits including low immunogeneci-
ty, convenient operability, and large-scale manufacturability 
[1]. Because polycations can condense with DNA as a result 
of electrostatic interactions, form nanosize polyplexes, and 
protect DNA from degradation by DNase, cationic polymer 
becomes a major type of non-viral gene delivery vectors 
(Figure 1) [2]. A wide range of polymeric vectors have been 
developed and investigated in the past decade, such as poly-
ethylenimine (PEI)-based vectors, poly(L-lysine) (PLL)- 
based vectors, dendrimer-based vectors, polypeptide-based 
vectors, and chitosan-based vectors [3]. However, unlike 
viral vectors that have the ability to infect host cells and 
overcome cellular barriers through the course of evolution, 
nonviral gene vectors exhibit significantly reduced transfec-
tion efficiency as they are obstructed by various extra- and 
intracellular barriers, including serum proteins in blood 
stream, cell membrane, endosomal compartment and nucle-
ar membrane [4].  
As a result, numerous studies have focused on designing 
polymer carriers that have smart molecular structure, pre-
sent good biocompatibility, avoid both in vitro and in vivo 
barriers, and achieve successful delivery of genetic material 
[1]. To circumvent different systemic and cellular obstacles  
 
Figure 1  Three main strategies employed to package DNA [4]. 
during gene delivery, proper functional groups were conju-
gated to polymeric vectors. The current modification of 
polymeric vectors has shown great improvements in en-
hancing intracellular gene transfer efficiency and attaining 
tumor targeted gene delivery [4]. For example, receptor- 
mediated cell uptake can quickly deliver ligand-targeted 
polyplexes into endosomes, membrane active compounds 
(lipids and peptides) can enhance the release of endocy-
tosed materials. Moreover, nuclear localization signal pep-
tides can enhance both the nuclear transport and expres-
sion of DNA. Here, current research progress regarding 
polymeric gene vectors that mainly published in Chinese 
magazines from 2010 was reviewed, and future trends for 
the polymer-based gene delivery systems would also be 
delineated.  
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1  Commonly used polymeric gene vectors 
1.1  Polyethyleneimine (PEI) based vectors 
Among all the commonly used polymeric gene vehicles, 
polyethyleneimine (PEI) is the most prominent one because 
of its strong buffering capability, high DNA binding capa-
bility as well as high transfection efficiency (e.g., 25 kD 
PEI has been considered as the gold standard of gene trans-
fection). However, high molecular weight and charge den-
sity of PEIs also brought high cytotoxicity, which seriously 
limited their clinical application [5]. On the contrary, low 
molecular weight PEIs (MW<2000) have relatively low 
cytotoxicity, but present unsatisfactory gene transfer capa-
bility. To overcome this inconsistency, an extensive variety 
of modifications has been used and could be divided into 
two main approaches. 
The first approach is surface modification of PEI using 
biodegradable or biocompatible polymers (e.g., PEG, cy-
clodextrin, dextran) in order to minimize the toxicity of PEI 
molecules and enhance their serum stability [1]. Pei et al. 
used polyethyleneimine-g-methoxy poly(ethylene glycol) 
(PEI-g-MPEG) to mediate interleukin-10 (IL-10) gene de-
livery into rat dorsal root ganglion cells [6]. As compared 
with Lipofectamine2000, higher IL-10 expression and lower 
cytotoxicity could be found in PEI-g-MPEG/IL-10 com-
plexes transfected cells after 48 h, indicating that PEI-g- 
MPEG could be a potential candidate for gene delivery 
during the therapy of neuropathic pain. Deng’s group [7] 
applied PEG-g-PEI/DNA to transfect mesenchymal stem 
cells. Results indicated that PEG-g-PEI could completely 
protect DNA against DNase I, formed PEG-g-PEI/DNA 
nanoparticles of 100150 nm and obtained higher transfec-
tion efficiency and lower toxicity than cationic liposome.  
The other approach is to synthesize various biodegrada-
ble PEI compounds via reducible disulfide linkages or ester 
conjugation. These compounds present high positive charg-
es, but can degrade into nontoxic low molecular weight 
PEIs in the physiological environment. Zhuo’s group [4] 
has developed a series of disulfide crosslinked PEIs (Figure 
2). Recently, they designed a biotinylated transferrin/avidin/ 
biotinylated disulfide containing PEI bioconjugates (TABP- 
SS) mediated p53 gene delivery system [8]. As compared 
with jetPEI, this system exhibited much lower cytotoxicity, 
higher transfection efficacy, and induced more obvious 
apoptosis in HepG2 and HeLa cells due to the specific in-
teractions between transferrin ligands and their receptors on 
tumor cells. Chen’s group [9] crosslinked low molecular 
weight polyethylenimine-poly(γ-benzyl L-glutamate) (PEI- 
PBLG) to obtain CBA-PEI-PBLG(CPP). This compound 
has good reducible property, and also has good biocompati-
bility because of introducing PBLG segment. CPP/DNA 
complexes showed higher transfection efficiencies and low-
er cytotoxicity in HeLa cells. Wang’s group [10] developed 
cyclic phosphoester monomer ethyl ethylene phosphate  
 
Figure 2  Formation of disulfide containing PEI/DNA complexes [4]. 
(EEP) modified PEI (PEI-g-EEP) for gene delivery. They 
found that transfection efficiency of PEI-g- EEP/DNA 
complexes was correlated to modification degrees with 
phosphoester. When the modification of phosphoester to 
PEI was moderate, PEI-g-EEP/DNA complexes exhibited 
comparable or even higher transfection ability than PEI/ 
DNA complex at its optimal N/P ratio in the absence of 
serum; otherwise, transfection efficiency reduced dramati-
cally.  
Small interfering RNA (siRNA), as a potential tool for 
gene therapy, also requires suitable vehicles for stable com-
plexation, protection, low cytotoxicity and high efficiency 
of gene knockdown. Xiao et al. [11] synthesized (dextran- 
hexamethylenediisocyanate)-g-polyethylenimine ((Dex- 
HMDI)-g-PEI) as a siRNA vector. They found that the 
complexation of siRNA with the polycation can signifi-
cantly knock down the expression of enhanced green fluo-
rescent protein (EGFP). 
1.2  Poly(amidoamine) dendrimer based vectors 
Besides PEI, various other polymers have been synthesized 
and investigated for gene transfer. Dendrimers are perfect 
monodisperse macromolecules with a regular and highly 
branched three-dimensional architecture and may be syn-
thesized to reach nanometric sizes [1]. Their well-defined 
architectures, highly-branched structures, high density of 
functional terminal groups, and controllable molecular 
weights offer great potential for gene delivery. 
Poly(amidoamine) (PAMAM) dendrimer is the most com-
mon class of dendrimers suitable for gene transfer. Wen et 
al. [12] conjugated histidine to the surface of PAMAM G4 
using aminolysis reaction to construct a PAMAM derivative 
(His-PAMAM G4) as a new gene vector. Experimental re-
sults revealed that His-PAMAM G4 could sufficiently con-
dense DNA, reduce toxicity and enhance transfection effi-
ciency in serum as compared to PAMAM G4. Zhuo’s group 
[13] found that PAMAM with pendant aminobutyl group 
demonstrated higher transfection efficiency and percentage 
of nuclear localization than 25 kD PEI. This compound also 
exhibited better tissue compatibility, reflected by no or less 
inflammatory response in the site of muscle injection. Re-
cently, Gu’s group [14] reviewed the development of pep-
tide dendrimers with emphasis on their applications both in 
diagnostics and in therapy. 
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1.3  Polypeptide based vectors 
Among various non-viral gene delivery methods, using nat-
ural or artificial polypeptides with certain biological func-
tions is considered as one promising approach. Unlike other 
vectors, peptides have low cytotoxicity, greater biodegrada-
bility, and also serve different functions. For example, ly-
sine and/or arginine-rich cationic peptides can condense 
DNA into compact particles, TAT-based cell-penetrating 
peptides can disrupt the endosomal membrane, nuclear lo-
calization signal (NLS) peptides can traffic DNA to the nu-
cleus, and RGD-rich peptides can target polyplexes to spe-
cific receptors [15]. These properties may all be part of a 
single peptide sequence or a combination of peptides chem-
ically conjugated to form a vector capable of packaging and 
targeting DNA for efficient delivery.  
Recently, Zhuo’s group [16] introduced an iodine atom 
to nuclear localization signal (PKKKRKV) by chemically 
attaching 2-iodobenzoic acid to the peptide to obtain NLS-I 
peptide for cell targeting and nuclear transport. They found 
that cell internalization and nuclear accumulation of NLS-I 
was markedly increased compared to NLS in MCF-7 cells, 
and gene expression by PEI1800/DNA/NLS-I complexes 
exhibited much enhanced efficiency (up to 130-fold). This 
study demonstrates an alternative method to construct 
non-viral delivery system for targeted gene transfer into 
breast cancer cells. They also synthesized arginine-rich 
amphiphilic lipopeptides with hydrophobic aliphatic tails 
(C12GR8GDS and C18GR8GDS) as functional gene vectors 
[17]. They found that these lipopeptides exhibited very low 
cytotoxicity even at high concentration, and could be spe-
cifically recognized by cancer cells due to the incorporation 
of arginine-glycine-aspartic acid (RGD) sequences (specif-
ically recognized by integrins αυβ3 and αυβ5 over-expressed 
on cancer cells).  
Chen’s group [18] grafted RGD peptides to the carboxyl 
groups of poly(glutamic acid) to get a targeting shielding 
carrier (PGA-RGD) for PEI gene carrier. The experiment 
results showed that PGA-RGD can effectively shield 
PEI/DNA complex particles. For PGA-RGD/PEI/DNA 
shielding system, although its surface charges were de-
creased by PGA-RGD shielding, its gene transfection effi-
ciency was effectively improved because of the specific 
binding affinity between RGD and receptors on tumor en-
dothelial cell membranes.  
Chen’s group [19] indicated that multifunctional and 
multiplexed nanoparticles, as the next generation of nano-
particles, are now being extensively investigated and are 
promising tools to achieve personalized and tailored cancer 
treatments. In a recent review from Zhuo’s group [20], they 
reported that stimulus-responsive polymeric nanoparticles, 
which can change their structures, shapes, and properties 
after being exposed to external signals (including pH, tem-
perature, magnetic field, photo, etc.), are considered as the 
most promising materials for biomedical applications in-
cluding drug delivery, gene delivery and imaging. To in-
crease the in vivo stability of polycation gene carriers, 
Chen’s group [21] synthesized a pH-sensitive shielding 
system, γ-benzyll-glutamate-co-glutamate acid polymer 
(PGA(60)). This compound showed pH sensitivity at about 
pH 6.0, and could efficiently shield the positive charge of 
DNA/PEI complexes. The transfection efficiency was im-
proved when the positive charge was partly shielded by 
PGA(60). As the suitable pH sensitive range, PGA(60) may 
be a potential shielding system for polycation gene carriers 
to be used in vivo. Xu and Lu synthesized a series of multi-
functional spermine-based pH-sensitive amphiphilic carriers, 
which exhibited pH-sensitive cell membrane disrupting ac-
tivity and low cytotoxicity [22]. These compounds resulted 
in more than 400 times higher luciferase transfection effi-
ciency than that of Lipofectamine-2000 in U87 cells. 
2  Future trends 
Although intensive studies have been made on nonviral 
gene vectors and numerous research papers were published 
in recent years, their commercial development and human 
clinical application were still limited. Therefore, great em-
phasis should be placed on in vivo trials and development of 
new commercial transfection agents during the next decade. 
In order to obtain the permission for clinical application of 
non-viral gene vector mediated gene therapy, we need to 
make sustained efforts to combine those efficient synthetic 
vectors with therapeutic genes, make clinical safety assess-
ment, and provide indications how animal models correlate 
with clinical experience.  
Currently, we have to confront challenges associated 
with cell targeting specificity, gene transfer efficiency, gene 
expression regulation, and vector safety. Hence, the suc-
cessful non-viral vectors for future gene therapy must be 
multifunctional systems, and will be more efficient in tar-
geting and transfection. As a result, peptide-base vectors 
have great potential for gene delivery as numerous new 
functional peptides will be continuously discovered, and 
they have the ability to achieve these goals alone or in com-
bination with other systems. Moreover, polymeric vectors 
should preferably be biocompatible and biodegradable to 
prevent carrier-induced toxicities and the accumulation of 
carrier components in the host. Accordingly, more efforts 
should be made in order to facilitate DNA release where 
low Mw polymers are crosslinked or linearly linked togeth-
er by degradable linkages to form a high MW polymer that 
can eventually degrade to its lower MW components. It is 
very important for us to remember the mechanisms, appli-
cations and limitations of current gene delivery systems, 
and get more novel information from chemical, medical, 
biological and various fields so as to design innovational 
successful gene vectors.  
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